Skip to product information
1 of 1

GLAXOSMITHKLINE C.HEALTH.SpA

Rinazina Decongestant Nasal Spray 15ml 0.1%

Rinazina Decongestant Nasal Spray 15ml 0.1%

Regular price €11,05 EUR
Regular price Sale price €11,05 EUR
Sale Sold out
Tax included. Shipping calculated at checkout.
Logo Farmaci da banco

PRODUCT NET WEIGHT

15ml

EAN

000590051

MINSAN

000590051

View full details

Rinazina Nasal Spray is a nasal decongestant based on Naphazoline. Rinazina Nasal Spray is useful in cases of acute catarrhal rhinitis and pharyngitis, allergic rhinitis and acute sinusitis .

Rinazina Decongestant Nasal Spray 15ml combats the symptoms of seasonal allergies.

ACTIVE INGREDIENTS

Active ingredients contained in Rinazina Decongestant Nasal Spray 15ml 0.1% - What is the active ingredient of Rinazina Decongestant Nasal Spray 15ml 0.1%?

1 ml of solution contains, active ingredient: naphazoline nitrate 1 mg. Excipients with known effect: benzalkonium chloride. For the full list of excipients, see section 6.1.

 

EXCIPIENTS

Composition of Rinazina Decongestant Nasal Spray 15ml 0.1% - What does Rinazina Decongestant Nasal Spray 15ml 0.1% contain?

Rinazina 1 mg/ml nasal drops, solution: sodium chloride, disodium edetate, sodium phosphate monobasic dihydrate, concentrated phosphoric acid, benzalkonium chloride, purified water. Rinazina 1 mg/ml nasal spray, solution: sodium chloride, disodium edetate, sodium phosphate monobasic dihydrate, concentrated phosphoric acid, benzalkonium chloride, balsamic aroma, purified water.

 

DIRECTIONS

Therapeutic indications Rinazina Decongestant Nasal Spray 15ml 0.1% - Why is Rinazina Decongestant Nasal Spray 15ml 0.1% used? What is it for?

Nasal decongestant in the course of acute catarrhal rhinitis and pharyngitis, allergic rhinitis, acute sinusitis.

 

CONTRAINDICATIONS SIDE EFFECTS

Contraindications Rinazina Decongestant Nasal Spray 15ml 0.1% - When should Rinazina Decongestant Nasal Spray 15ml 0.1% not be used?

Hypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1; severe heart disease and arterial hypertension; glaucoma; hyperthyroidism; the medicinal product is contraindicated in children under 12 years of age. Do not administer during and for two weeks following therapy with antidepressant drugs.

 

DOSAGE

Quantity and method of taking Rinazina Decongestant Nasal Spray 15ml 0.1% - How do you take Rinazina Decongestant Nasal Spray 15ml 0.1%?

Nasal drops; adults: 2-3 drops in each nostril, 2-3 times a day. Nasal spray; adults: 1-2 sprays in each nostril, 2-3 times a day. Paediatric population: the medicine is contraindicated in children under 12 years of age (see section 4.3). Strictly adhere to the recommended doses. A higher dosage of the product even if taken topically and for a short period of time can give rise to serious systemic effects. In the absence of a complete therapeutic response within a few days, consult your doctor; in any case, treatment should not be continued for more than a week.

 

CONSERVATION

Storage Rinazina Decongestant Nasal Spray 15ml 0.1% - How is Rinazina Decongestant Nasal Spray 15ml 0.1% stored?

Rinazina 1 mg/ml nasal spray, solution: This medicine does not require any special storage conditions. Rinazina 1 mg/ml nasal drops, solution: Store below 25 degrees C. Store upright.

 

WARNINGS

Warnings Rinazina Decongestant Nasal Spray 15ml 0.1% - About Rinazina Decongestant Nasal Spray 15ml 0.1% it is important to know that:

Use with caution in the elderly and in those with prostatic hypertrophy due to the risk of urinary retention. In patients with cardiovascular disease, especially hypertensive patients, the use of nasal decongestants must be subjected to the doctor's judgment from time to time. Prolonged use of vasoconstrictors can alter the normal function of the nasal mucosa and paranasal sinuses, also inducing addiction to the drug. Repeated applications for a long period of time can be harmful. Rinazina nasal drops and nasal spray contain 0.1 mg/ml of benzalkonium chloride. Benzalkonium chloride (BAC) contained as a preservative in Rinazina nasal drops and nasal spray can cause irritation and swelling of the nasal mucosa, especially if used for long periods. If such a reaction is suspected (persistent nasal congestion), a nasal medicine without BAC should be used, if possible. If such nasal medicinal products without BAC are not available, another pharmaceutical form should be considered. May cause bronchospasm. Use, especially if prolonged, of topical products may give rise to sensitization phenomena; in this case, treatment should be stopped and, if necessary, appropriate therapy should be instituted. Rare cases of posterior reversible encephalopathy/reversible cerebral vasoconstriction syndrome have been reported with the use of sympathomimetic drugs, to which naphazoline also belongs. Reported symptoms include sudden onset of severe headache, nausea, vomiting and visual disturbances. Most cases improve or resolve within a few days following appropriate treatment. Use of naphazoline should be stopped immediately and a doctor should be consulted if signs and/or symptoms of posterior reversible encephalopathy/reversible cerebral vasoconstriction syndrome occur.

 

INTERACTIONS

Interactions Rinazina Decongestant Nasal Spray 15ml 0.1% - Which medicines or foods can modify the effect of Rinazina Decongestant Nasal Spray 15ml 0.1%?'

The drug may interact with antidepressant drugs.

 

SIDE EFFECTS

Like all medicines, Rinazina Decongestant Nasal Spray 15ml 0.1% can cause side effects - What are the side effects of Rinazina Decongestant Nasal Spray 15ml 0.1%?

The product may locally cause rebound phenomena of sensitization and congestion of the mucous membranes. Due to rapid absorption of naphazoline through inflamed mucous membranes, systemic effects may occur consisting of arterial hypertension, reflex bradycardia, headache, urination disorders. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

 

PREGNANCY AND BREASTFEEDING

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Rinazina Decongestant Nasal Spray 15ml 0.1%.

During pregnancy and breastfeeding, Rinazina should be used only after consulting your doctor and evaluating with him the risk/benefit ratio in your case.

  • HELP CENTER

  • SHIPPING

    Shipping in Italy 24/48H
    Delivery also on Saturday and Sunday
    Free over €49.90


    Shipping in Europe 24/72H
    Free over €80


    Shipping to UK 24/72H
    Free over €150

  • SAFETY

    The security of your data matters to us!


    We are fully compliant with the European GDPR regarding Privacy and Processing of personal data.


    Payments you make on our site are 100% safe and guaranteed.

  • RETURNS

    Fast returns through do-it-yourself portal and 14 days to reconsider.


    Fast and free replacements for incorrect or non-compliant products delivered.

1 of 4

Responsibility for content
This sheet contains information that is not intended to replace a diagnosis or medical advice, as only a doctor can write any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.

Please note
The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they could be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the published information.

Data source: Farmadati Italia
Website: https://www.farmadati.it/

The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalists, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory.

The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.